IncFact
Company Profiles: Revenue, Growth, Competition

VERTEX PHARMACEUTICALS Revenue, Growth & Competitor Profile

DBA VERTEX PHARMACEUTICALS INC / MA
Last updated:

Company Awards

Big Fish
Big Fish
 
Public Company
public company
Brain Power (IP)
Patent/Trademark IP
 
VC / Private Equity
Venture Capital / Private Equity

Company Profile & Annual Report for Vertex Pharmaceuticals

Access the complete profile.

Vertex Pharmaceuticals Fast Facts

RevenueOver $500 million    See Exact Annual Revenue
EmployeesOver 1,000Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
Address50 Northern Ave.
Boston, MA 02210

www.vrtx.com


Vertex Pharmaceuticals's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Scientific Research & Development Services industry.


Vertex Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Vertex Pharmaceuticals is a publicly traded company on NASDAQ using the ticker symbol VRTX. Detailed information on company financials and operating reports can be found here: NASDAQ: VRTX



Vertex Pharmaceuticals Annual Revenue and Growth Rate

Vertex Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2016 Details in Premium Report
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Vertex Pharmaceuticals's revenues are gauged from an analysis of company filings.



Investor Activity

Vertex Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
March 18, 2009 3 100%$2 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Vertex Pharmaceuticals is developing and marketing. Vertex Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
TRIKAFTA
Pharmaceutical preparations for the treatment of cystic fibrosis
04/25/2018
AKAFTREO
Pharmaceutical preparations for the treatment of cystic fibrosis
03/29/2018
KLYTREOS
Pharmaceutical preparations for the treatment of cystic fibrosis
03/29/2018

See all trademarks and details in the Full Report.


Patent Applications

Patent applications show Vertex Pharmaceuticals's intellectual property, its current capabilities and future direction. Vertex Pharmaceuticals has applied for 663 patents since 2009. Vertex Pharmaceuticals's most recent patent was filed in October 2018 for Modulators Of Atp-binding Cassette Transporters. Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.


Patent Application Date
Complete list of patent applications




Recession Risk

Determine whether Vertex Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Vertex Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Competition: Vertex Pharmaceuticals vs. Largest Competitors

A competitive analysis shows these companies are in the same general field as Vertex Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
SYNEOS HEALTHRaleigh, NC100 
ALEXION PHARMACEUTICALSNew Haven, CT88 
LEIDOS HOLDINGSReston, VA79 
CEPHALONFrazer, PA70 
VERTEX PHARMACEUTICALSBoston, MA61 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM59 




Nearby Competitors

These companies are similar in business line and location to Vertex Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
VERTEX PHARMACEUTICALSBoston, MA100 
BAIM INSTITUTE FOR CLINICAL RESEARCHBoston, MA1 
GINKGO BIOWORKSBoston, MA1 
EMULATEBoston, MA1 
CYTONOME ST.Boston, MA1 
CAMBRIAN INNOVATIONBoston, MA0 




Similar Sized Companies near Boston

These are similar in size and location to Vertex Pharmaceuticals.

Company HeadquartersRevenue ($ MM)
CABOTBoston, MA7 
FMRBoston, MA100 
CENGAGE LEARNINGBoston, MA5 
BAYSTATE HEALTH SYSTEM HEALTH SERVICESBoston, MA4 
BETH ISRAEL DEACONESS MEDICAL CENTERBoston, MA4 
CIVITAS SOLUTIONSBoston, MA3 
NATIONAL MENTOR HOLDINGSBoston, MA3 
WELLINGTON MANAGEMENTBoston, MA2 




Fastest Growing Competitors

These companies are in the same general field as Vertex Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Vertex Pharmaceuticals Competitors